|
KPNB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.777600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.154400E-01 |
| Normal-vs-Stage2 |
6.950200E-01 |
| Normal-vs-Stage3 |
1.389210E-01 |
| Normal-vs-Stage4 |
4.067200E-01 |
| Stage1-vs-Stage2 |
2.240800E-01 |
| Stage1-vs-Stage3 |
3.361200E-01 |
| Stage1-vs-Stage4 |
9.127600E-01 |
| Stage2-vs-Stage3 |
7.875600E-02 |
| Stage2-vs-Stage4 |
2.674400E-01 |
| Stage3-vs-Stage4 |
5.491000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.983200E-01 |
| Normal-vs-AfricanAmerican |
6.741800E-01 |
| Normal-vs-Asian |
3.116000E-01 |
| Caucasian-vs-AfricanAmerican |
2.481600E-01 |
| Caucasian-vs-Asian |
8.609200E-01 |
| AfricanAmerican-vs-Asian |
2.363000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.525800E-01 |
| Normal-vs-Female |
3.756200E-01 |
| Male-vs-Female |
8.889400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.647200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.185210E-01 |
| Normal-vs-Age(61-80Yrs) |
9.267200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.763000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.001400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.528000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.218000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.414000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.649800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.226000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.540400E-01 |
| Classical-VS-Follicular |
3.444800E-01 |
| Classical-VS-Other |
3.220400E-01 |
| Classical-VS-Normal |
7.230400E-01 |
| Tall-VS-Follicular |
9.687800E-01 |
| Tall-VS-Other |
5.900800E-01 |
| Tall-VS-Normal |
3.781800E-01 |
| Follicular-VS-Other |
6.050600E-01 |
| Follicular-VS-Normal |
3.105200E-01 |
| Other-VS-Normal |
2.523000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.184200E-01 |
| Normal-vs-N1 |
5.940100E-02 |
| N0-vs-N1 |
2.305800E-01 |
|
|
